Two SPAC Deals to Start the Week

by | Apr 25, 2022

Two med-related SPAC deals. Convert and PIPE action. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

SPAC Deal: DKDCA + OneMedNet

Data Knights Acquisition Corp.(DKDCA) announced a DA with OneMedNet. The transaction values OneMedNet, the ‘leading curator of regulatory-grade Imaging Real Word Data (RWD), at an enterprise value of approximately $317 million. No PIPE. Expected completion in the second half of 2022.

SPAC Deal: XPAX + SuperBac

Data Knights Acquisition Corp.(XPAX) announced a DA with SuperBAC, a Brazil-based biotech. The transaction values SuperBAC at a post-money enterprise value of approximately $500 million. Expected completion in the second half of 2022. Slide deck here.

Convert for BOAS / Selina Hotels

BOA Acquisition Corp. (BOAS) announced that Selina Hospitality PLC has entered into agreements for a $147.5 million of 6% senior unsecured convertible notes due 2026. This additional financing is expected to close concurrently with the SPAC merger with BOAS and allow Selina to realize its multi-year business plan. Selina is a lifestyle and experiential hospitality brand targeting Millennial and Gen Z travelers.

Upsized PIPE for ITHX / Mondee

ITHAX Acquisition Corp (ITHX) / announces upsized PIPE for Mondee to $70M up from $50M, from “two leading financial investors.”

Elsewhere in SPACs

  • EdtechX Holdings Acquisition Corp. II (EDTX) files for an extension from June to December. SPAC has ~$10.15 in trust. Doesn’t appear to be adding additional cash to trust.
  • Altitude Acquisition Corp. (ALTU) is gearing up for an extension vote. Current deadline of 6/11. Signed an LOI on 3/1.

Upcoming Merger and Extension Votes

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.